Cardio-Metabolic Diseases

Cardiometabolic syndrome (CMS) is a group of metabolic dysfunctions that are mainly characterized by insulin resistance, impaired glucose tolerance, dyslipidaemia, hypertension, and central adiposity. World Health Organization and the American Society of Endocrinology now recognized CMS as a disease entity. Patients with CMS have more chances to die from coronary heart disease, heart attack or stroke. Cardio metabolic programs and therapeutic strategies that combine diet and exercise prescriptions help to reduce cardiometabolic risk factors.  Treatment strategies include

  • Moderate physical activity
  • Weight reduction or Weight-Loss Surgery
  • Blood pressure control
  • Correction of dyslipidaemia
  • Glycaemic

Related Conference of Cardio-Metabolic Diseases

July 29-30, 2025

15th World Congress on Endocrinology and Diabetes

Paris, France
September 08-09, 2025

3rd World congress and Expo on Diabetes

Frankfurt, Germany
October 27-28, 2025

5th World Congress on Endocrine and Diabetes

Madrid, Spain
October 30-31, 2025

5th Annual Summit on Diabetes and Endocrinology

Paris, France
November 03-04, 2025

34th European Diabetes Congress

Rome, Italy
November 06-07, 2025

8th Annual Meeting on Diabetes and Endocrinology

Dubai, UAE
November 20-21, 2025

21st World Congress on Endocrinology & Diabetes

Paris, France
November 24-25, 2025

6th International conference on Diabetic complications

Barcelona, Spain
February 23-24, 2026

19th International Summit on Diabetes

London, UK
March 26-27, 2026

7th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands
May 18-19, 2026

57th Annual Congress on Endocrinology and Diabetes Research

Aix-en-Provence, France
September 23-24, 2026

24th Global Conference on Diabetes, Endocrinology and Primary Healthcare

Aix-en-Provence, France

Cardio-Metabolic Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in